Paragon 28 Inc Revenue Growth Rates (FNA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Paragon 28 inc   (NYSE: FNA)
 

FNA's Revenue Growth by Quarter and Year

Paragon 28 Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FNA Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 72.32
3rd Quarter September 62.18
2nd Quarter June 60.76
1st Quarter March 60.24
FY 255.50





FNA Revenue fourth quarter 2024 Y/Y Growth Comment
Paragon 28 inc achieved in the fourth quarter 2024, above Company average Revenue growth of 20.53% year on year, to $ 72.32 millions.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 66 other companies have achieved higher Revenue growth. While Paragon 28 Inc ' s Revenue rise of 20.53% ranks overall at the positon no. 1021 in the fourth quarter 2024.


FNA Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 20.53 % 16.48 % 20.41 % 41.33 %
3rd Quarter September 18.69 % 13.87 % 28.34 % -
2nd Quarter June 19.11 % 20.02 % 18.95 % -
1st Quarter March 15.76 % 25.79 % 24.98 % -
FY   18.59 % 18.77 % 23.01 % -

Financial Statements
Paragon 28 Inc 's fourth quarter 2024 Revenue $ 72.32 millions FNA's Income Statement
Paragon 28 Inc 's fourth quarter 2023 Revenue $ 60.00 millions Quarterly FNA's Income Statement


FNA Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December 16.3 % 14.53 % 11.95 % 19.33 %
3rd Quarter September 2.34 % 2.71 % 8.26 % 0.34 %
2nd Quarter June 0.86 % -1.98 % 2.73 % 7.95 %
1st Quarter March 0.4 % 1.03 % -3.3 % 9.35 %
FY (Year on Year)   18.59 % 18.77 % 23.01 % -


Back to FNA Growth rate Comparisons >> Back to FNA Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #228
Overall #1021

Revenue Y/Y Growth Statistics
High Average Low
28.33 % 20.1 % 13.87 %
(Jun 30 2023)   (Jun 30 2024)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #228
Overall #1021
Revenue Y/Y Growth Statistics
High Average Low
28.33 % 20.1 % 13.87 %
(Jun 30 2023)   (Jun 30 2024)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Paragon 28 Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
19.31 % 5.56 % -3.28 %
(Dec 31 2021)  


FNA's IV. Quarter Q/Q Revenue Comment
Paragon 28 inc achieved in the IV. Quarter 2024 above company average sequential Revenue jump of 16.3%, to $ 72.32 millions, from $62.18 millions in the third quarter.
FNA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 54 other companies have achieved higher Revenue quarter on quarter growth. While Paragon 28 Inc 's Revenue growth quarter on quarter, overall rank is 901.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #55
Healthcare Sector #195
Overall #901
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #55
Healthcare Sector #195
Overall #901
Revenue Q/Q Growth Statistics
High Average Low
19.31 % 5.56 % -3.28 %
(Dec 31 2021)  


FNA's IV. Quarter Q/Q Revenue Comment
Paragon 28 inc achieved in the IV. Quarter 2024 above company average sequential Revenue jump of 16.3%, to $ 72.32 millions, from $62.18 millions in the third quarter.
FNA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 54 other companies have achieved higher Revenue quarter on quarter growth. While Paragon 28 Inc 's Revenue growth quarter on quarter, overall rank is 901.


Paragon 28 Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 255.49 $ 243.17 $ 233.39 $ 223.64 $ 215.44
Y / Y Revenue Growth (TTM) 18.59 % 17.51 % 16.37 % 16.45 % 18.77 %
Year on Year Revenue Growth Overall Ranking # 695 # 73 # 63 # 0 # 0
Seqeuential Revenue Change (TTM) 5.06 % 4.19 % 4.36 % 3.81 % 4.1 %
Seq. Revenue Growth (TTM) Overall Ranking # 1771 # 1398 # 99 # 0 # 0


Cumulative Revenue growth Comment
Although Paragon 28 Inc 's Annual Revenue growth year on year were below company's average 49.56% , Revenue announced in the Dec 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 18.59% year on year, from 17.51% in Sep 30 2024.

In the Healthcare sector 165 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 73 to 695.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 101
Healthcare Sector # 166
Overall # 695

Revenue TTM Y/Y Growth Statistics
High Average Low
139.13 %
 49.56 %
16.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 101
Sector # 298
S&P 500 # 1771
Cumulative Revenue growth Comment
Although Paragon 28 Inc 's Annual Revenue growth year on year were below company's average 49.56% , Revenue announced in the Dec 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 18.59% year on year, from 17.51% in Sep 30 2024.

In the Healthcare sector 165 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 73 to 695.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 101
Healthcare Sector # 166
Overall # 695

Revenue TTM Y/Y Growth Statistics
High Average Low
139.13 %
49.56 %
16.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 101
Sector # 298
S&P 500 # 1771




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FNA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Atrium Therapeutics Inc 35.57%$ 35.568 millions
Xeris Biopharma Holdings Inc 35.39%$ 35.389 millions
Alnylam Pharmaceuticals Inc 34.90%$ 34.897 millions
Corcept Therapeutics Inc34.33%$ 34.330 millions
Pro dex Inc 33.40%$ 33.405 millions
Therapeuticsmd Inc 32.87%$ 32.869 millions
Aurinia Pharmaceuticals Inc 32.76%$ 32.758 millions
Euda Health Holdings Limited32.37%$ 32.374 millions
Nexalin Technology Inc 32.27%$ 32.271 millions
Caredx Inc 32.04%$ 32.043 millions
Nuwellis Inc 31.92%$ 31.922 millions
Mannkind Corporation31.30%$ 31.304 millions
Lifevantage Corp31.05%$ 31.050 millions
Castle Biosciences Inc 30.54%$ 30.537 millions
Ethema Health Corporation 30.39%$ 30.392 millions
Nephros Inc 30.28%$ 30.277 millions
Guardant Health Inc 30.16%$ 30.157 millions
Amicus Therapeutics inc 30.09%$ 30.086 millions
Glaukos Corp29.85%$ 29.847 millions
Rapid Micro Biosystems Inc 29.68%$ 29.683 millions
Avita Medical Inc 29.67%$ 29.665 millions
Dynavax Technologies Corporation29.56%$ 29.561 millions
Halozyme Therapeutics Inc 29.55%$ 29.547 millions
International Stem Cell Corporation29.49%$ 29.487 millions
Ultragenyx Pharmaceutical Inc 29.42%$ 29.425 millions
Evolus Inc 29.42%$ 29.423 millions
The Pennant Group Inc 29.42%$ 29.419 millions
Brainsway Ltd 29.04%$ 29.042 millions
Alphatec Holdings Inc 28.94%$ 28.940 millions
Si bone inc 28.45%$ 28.450 millions


About Paragon 28 Inc Revenue Growth Rates (FNA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Paragon 28 Inc (CIK 1531978).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-25-002386
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Paragon 28 Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.